Citations

Mayo Clinic

Showing 10 of 108523 citations.

Musculoskeletal Diseases as the Most Prevalent Component of Multimorbidity: A Population-Based Study
Rajović, Nina , Zagorac, Slaviša , Ćirković, Andja , Matejić, Bojana , Jeremić, Danilo , Tasic, Radica , Cumic, Jelena, Mašić, Srdjan , Grupkovic, Jovana , Mitrović, Vekoslav , Gluščević, Boris , Gluscevic, Boris , Rajovic, Nina , Masic, Srdjan , Milić, Nataša

Journal of Clinical Medicine | May 24, 2024 | Volume: 13 | Issue: 11 | Pages: 3089

10.3390/jcm13113089 | PMID 38892800 Get It

Background/Objectives: Due to their high frequency, common risk factors, and similar pathogenic mechanisms, musculoskeletal disorders (MSDs) are more likely to occur with other chronic illnesses, making them a “component disorder“ of multimorbidity. Our objective was to assess the prevalence of multimorbidity and to identify the most common clusters of diagnosis within multimorbidity states, with the primary hypothesis that the most common clusters of multimorbidity are MSDs. Methods: The current study employed data from a population-based 2019 European Health Interview Survey (EHIS). Multimorbidity was defined as a ≥2 diagnosis from the list of 17 chronic non-communicable diseases, and to define clusters, the statistical method of hierarchical cluster analysis (HCA) was performed. Results: Out of 13,178 respondents, multimorbidity was present among 4398 (33.4%). The HCA method yielded six multimorbidity clusters representing the most common diagnoses. The primary multimorbidity cluster, which was prevalent among both genders, age groups, incomes per capita, and statistical regions, consisted of three diagnoses: (1) lower spine deformity or other chronic back problem (back pain), (2) cervical deformity or other chronic problem with the cervical spine, and (3) osteoarthritis. Conclusions: Given the influence of musculoskeletal disorders on multimorbidity, it is imperative to implement appropriate measures to assist patients in relieving the physical discomfort and pain they endure. Public health information, programs, and campaigns should be utilized to promote a healthy lifestyle. Policymakers should prioritize the prevention of MSDs by encouraging increased physical activity and a healthy diet, as well as focusing on improving functional abilities.
Unfolding Mystery of Aortic Transcatheter Valve Doppler Gradient and Clinical Outcomes
Eleid, Mackram F.

Circulation: Cardiovascular Interventions | May 24, 2024 | Volume: 17 | Issue: 7 | Pages: No page available

10.1161/circinterventions.124.014254 | PMID 38785083 Get It

Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism
Camilleri, Michael , Jencks, Kara J. , Jencks, Kara

Expert Opinion on Drug Metabolism & Toxicology | May 24, 2024 | Volume: 20 | Issue: 5 | Pages: 319-332

10.1080/17425255.2024.2349716 | PMID 38785066 Get It

Digital dermatopathology implementation: Experience at a multisite academic institution
Proffer, Sydney L. , Reinhart, Jacob P. , Gerdes, Erin Wissler, Todd, Austin, Cervenka, Derek J., DiCaudo, David J. , Sokumbi, Olayemi , Johnson, Emma F. , Peters, Margot S. , Wieland, Carilyn N. , Comfere, Nneka I. , Gerdes, Erin O. Wissler , Reinhart, Jacob , Sokumbi, Olayemi , Comfere, Nneka , Larkin, Sydney C , Wissler Gerdes, Erin O , Ridgeway, Jennifer L. , Barry, Barbara , Kamath, Celia

Journal of Cutaneous Pathology | May 24, 2024 | Volume: 51 | Issue: 9 | Pages: 696-704

10.1111/cup.14629 | PMID 38783791 Get It

AbstractBackgroundTechnology has revolutionized not only direct patient care but also diagnostic care processes. This study evaluates the transition from glass‐slide microscopy to digital pathology (DP) at a multisite academic institution, using mixed methods to understand user perceptions of digitization and key productivity metrics of practice change.MethodsParticipants included dermatopathologists, pathology reporting specialists, and clinicians. Electronic surveys and individual or group interviews included questions related to technology comfort, trust in DP, and rationale for DP adoption. Case volumes and turnaround times were abstracted from the electronic health record from Qtr 4 2020 to Qtr 1 2023 (inclusive). Data were analyzed descriptively, while interviews were analyzed using methods of content analysis.ResultsThirty‐four staff completed surveys and 22 participated in an interview. Case volumes and diagnostic turnaround time did not differ across the institution during or after implementation timelines (p = 0.084; p = 0.133, respectively). 82.5% (28/34) of staff agreed that DP improved the sign‐out experience, with accessibility, ergonomics, and annotation features described as key factors. Clinicians reported positive perspectives of DP impact on patient safety and interdisciplinary collaboration.ConclusionsOur study demonstrates that DP has a high acceptance rate, does not adversely impact productivity, and may improve patient safety and care collaboration.
Artificial Intelligence Assists in the Early Identification of Cardiac Amyloidosis
Kenyon, Courtney , Pereyra, Milagros , Rosenthal, Julie , Arsanjani, Reza , Kenyon, Courtney R , Pereyra, Milagros , Arsanjani, Reza

Journal of Personalized Medicine | May 24, 2024 | Volume: 14 | Issue: 6 | Pages: 559

10.3390/jpm14060559 | PMID 38929780 Get It

A 69-year-old female presented with symptomatic atrial fibrillation. Cardiac amyloidosis was suspected due to an artificial intelligence clinical tool applied to the presenting electrocardiogram predicting a high probability for amyloidosis, and the subsequent unexpected finding of left atrial appendage thrombus reinforced this clinical suspicion. This facilitated an early diagnosis by the biopsy of AL cardiac amyloidosis and the prompt initiation of targeted therapy. This case highlights the utilization of an AI clinical tool and its impact on clinical care, particularly for the early detection of a rare and difficult to diagnose condition where early therapy is critical.
Using Microfluidic Hepatic Spheroid Cultures to Assess Liver Toxicity of T-2 Mycotoxin
Taroncher, Mercedes , Gonzalez‐Suarez, Alan M. , Romero, Samuel, Reyes-Figueroa, A. D. , Rodríguez-Carrasco, Yelko , Ruiz, María-José , Stybayeva, Gulnaz , Revzin, Alexander , Hoyos‐Vega, José M. de , Reyes-Figueroa, Angel D , Rodríguez-Carrasco, Yelko , Ruiz, María-José , Stybayeya, Gulnaz , de Hoyos-Vega, Jose M , Gonzalez-Suarez, Alan M , Gwon, Kihak , Romero, Samuel

Cells | May 24, 2024 | Volume: 13 | Issue: 11 | Pages: 900

10.3390/cells13110900 | PMID 38891032 Get It

The Fusarium fungi is found in cereals and feedstuffs and may produce mycotoxins, which are secondary metabolites, such as the T-2 toxin (T-2). In this work, we explored the hepatotoxicity of T-2 using microfluidic 3D hepatic cultures. The objectives were: (i) exploring the benefits of microfluidic 3D cultures compared to conventional 3D cultures available commercially (Aggrewell plates), (ii) establishing 3D co-cultures of hepatic cells (HepG2) and stellate cells (LX2) and assessing T-2 exposure in this model, (iii) characterizing the induction of metabolizing enzymes, and (iv) evaluating inflammatory markers upon T-2 exposure in microfluidic hepatic cultures. Our results demonstrated that, in comparison to commercial (large-volume) 3D cultures, spheroids formed faster and were more functional in microfluidic devices. The viability and hepatic function decreased with increasing T-2 concentrations in both monoculture and co-cultures. The RT-PCR analysis revealed that exposure to T-2 upregulates the expression of multiple Phase I and Phase II hepatic enzymes. In addition, several pro- and anti-inflammatory proteins were increased in co-cultures after exposure to T-2.
Perceptions of Surgical Drains among Breast Reconstruction Patients and Health Care Staff: A Qualitative Survey Study
Tian, William M. , Rames, Jess D. , Schroeder, Brooke E. , Dunworth, Kristina , Yi, Victoria N. , Tran, Melissa, Gallagher, Jennifer, Hollenbeck, Scott T. , Gallagher, Jennifer, Bachelder, Robin E.

Journal of Reconstructive Microsurgery | May 23, 2024 | Volume: 41 | Issue: 02 | Pages: 156-161

10.1055/a-2332-0444 | PMID 38782029 Get It

Abstract Background Surgical drains are a key component for recovery in breast reconstruction procedures. However, they are often cumbersome and carry a risk of infection with prolonged use. We aimed to develop a more thorough understanding of patient and health care provider perspectives on surgical drains, to inform future efforts in improving the breast reconstruction patient experience. Methods Twenty-nine breast reconstruction patients and eight plastic surgery providers were recruited to complete surveys focused on surgical drains. Likert scales ranging from 1 to 5 were developed to gauge how bothersome drains felt, as well as concern for infection. Ordinal variable and categorical multiple-choice analyses were applied as appropriate. Results Fifteen (51.7%) patients underwent implant-based breast reconstruction, and 14 (48.3%) patients underwent autologous breast reconstruction. The most common duration of drain placement was 2 weeks (N = 13). The surgical site infection (SSI) rate requiring antibiotics was 28% (N = 8). On a scale of 1 to 5, both patients (median = 3) and providers (median = 2.5) viewed drains as bothersome. Patients were “frequently” concerned about infection risk (median = 3). Other high-frequency patient concerns included general pain and discomfort. Conclusion Surgical drains are a common component of breast reconstruction procedures and are viewed as cumbersome by both patients and providers. Patients expressed concerns about drain site pain, discomfort, and tugging on clothing. Patients and providers both believed that drains could contribute to SSI. Overall, these data provide insight to drive future improvements in the patient drain experience.
ICSNT Primer for the Skull Base Community: Navigating the Landscape of Sinonasal Tumors with Synthesized Literature Guidance
Adappa, Nithin D. , London, Nyall R. , Smith, Timothy L. , Su, Shirley Y. , Wang, Marilene B. , Adappa, Nithin D. , Kuan, Edward C , Holtzman, Adam L. , Wang, Marilene B , Su, Shirley Y , Wang, Eric W , Adappa, Nithin D. , Beswick, Daniel M.

Journal of Neurological Surgery Part B: Skull Base | May 23, 2024 | Volume: 86 | Issue: 03 | Pages: 373-376

10.1055/s-0044-1787155 | PMID 40351885 Get It

Low-contrast detectability of photon-counting-detector CT at different scan modes and image types in comparison with energy-integrating-detector CT
Fan, Mingdong, Zhou, Zhongxing , Wellinghoff, Jarod , Yu, Lifeng , McCollough, Cynthia H , Yu, Lifeng , McCollough, Cynthia H.

Journal of Medical Imaging | May 23, 2024 | Volume: 11 | Issue: S1 | Pages: No page available

10.1117/1.jmi.11.s1.s12803 | PMID 38799271 Get It

Using Federal, State, and Grassroots Advocacy to Effect Change in Cancer Care Delivery and Patient Outcomes in the United States
Persing, Brian, Kamboj, Jasmine , Hoxie, Gina, Sumrall, Ashley

American Society of Clinical Oncology Educational Book | May 23, 2024 | Volume: 44 | Issue: 3 | Pages: No page available

10.1200/edbk_433416 | PMID 38781556 Get It

Health policy influences health and well-being for patients with cancer. Advocating for evidence-based health policies that aim to prevent cancer, promote health, and improve efficiencies in the health care system is crucial to improving care delivery and cancer outcomes nationwide. The role of the ASCO's Government Relations Committee (GRC) is to advocate for policies at a federal and state level that promote high-quality and equitable cancer care, and ASCO volunteer engagement is critical for the success of creating, changing, and adopting policies that support patients with cancer and their care team. Cancer care professionals are uniquely positioned to advocate at all levels of government, local, state, and federal and to serve as invaluable resources for lawmakers as they work to implement policy changes. Lawmakers are highly responsive to cancer care providers as most lawmakers have family or friends who have been diagnosed with cancer. Multiple advocacy strategies that are effective and efficient in their approach have been used, making advocating feasible for cancer care professionals’ busy schedule. To improve patient care, ASCO’s GRC and ASCO volunteers advocate for increased federal funding for research, greater health care access, value in cancer care, and payment reform. ASCO’s GRC has many programs in place to support ASCO members interested in engaging in advocacy to improve the quality of care for their patients and the support for cancer care professionals to thrive in the field.